Pharma-suitable marine collagen peptides and protein for researchers and bioengineering startups
ben@3fpharma.com  |  709-325-0686

Ultra-Pure Marine Collagen

for Dermal, Wound, and Scaffold Systems

3F Pharma supplies high-purity marine collagen peptides and protein as an advanced material used in wound care matrices, dermal repair systems, and scaffold-based applications across biomedical and advanced materials research.

Our materials are designed for hydrated systems, skin-contact environments, and material-intensive scaffold platforms, with consistency and formulation clarity prioritized at research and pilot scale.

Materials Designed for Research-Scale and Translational Work

Collagen is widely studied not only for its biological familiarity, but for how it behaves as a material in hydrated matrices, structural layers, and composite systems. At early and mid-stage development, purity, molecular weight distribution, and handling behavior are often decisive variables.

3F Pharma’s collagen materials are supplied for research-scale and pilot programs where reproducibility, solubility, and matrix behavior must be evaluated without interference from fillers or additives.

Marine Collagen Peptides

Low molecular weight collagen peptides produced via controlled enzymatic hydrolysis.

  • >98% purity
  • Average molecular weight ~3 kDa
  • Controlled distribution (~1–6 kDa)
  • High solubility in aqueous systems
  • Odourless, colourless, tasteless profile

These characteristics are commonly evaluated in hydrated wound gels and matrices, dermal repair formulations, and diffusion-sensitive scaffold systems where uniform dispersion is required.

Native Marine Collagen Protein

Higher molecular weight collagen protein produced via cold controlled process without hydrolysis or thermal processing.

  • >96% purity
  • Species-dependent molecular weight ranges: Atlantic cod ~100–800 kDa; Nile tilapia ~100–650 kDa
  • Odourless, colourless, tasteless profile

Protein formats are commonly evaluated in wound dressings, films, and dermal matrices; skin graft substrates and structural layers; and scaffold backbones where matrix continuity is required.

Application Focus

  • Wound Care & Dermal Repair
  • Dermal & Skin Science (Biomedical + Cosmetic R&D)
  • Scaffold-Based Systems & Cellular Agriculture
  • Regenerative Medicine & ECM-Inspired Research
  • Human–Machine Interface & Soft Interface Research

Visit our Applications page for more information.

Research Context & Technical Perspective

3F Pharma maintains an active view of the Research Landscape surrounding collagen-based materials across wound care, dermal science, and scaffold systems. We also monitor emerging research at the intersection of soft tissue materials, artificial skin, and human–machine interfaces, where skin-contact and hydration remain central challenges.

Our Technical Perspectives section provides evidence-based discussion grounded in peer-reviewed research.

A Strategic Supply Partner for Translational Programs

3F Pharma operates at research and pilot scale today, with a clear path toward application-specific certification and GMP alignment.

Rather than pursuing blanket certification, we work with customers to define application requirements, align materials and specifications, and invest in certification where programs demonstrate traction. As customer applications progress, we grow capability alongside them.

Technical Discussion & Contact

Material behavior is application-specific and best evaluated through technical discussion.

Contact us to request material specifications, application guidance, research-scale and pilot supply discussion, and future certification pathways.

© 3257699 Nova Scotia Limited (operating as 3F Pharma)